Edaravone (Edaravone) Edaravone 30mg/100mL – ALS (IV solution)

Edaravone is a medication used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neuromuscular disease that affects motor neurons. Edaravone is a potent antioxidant that helps reduce oxidative stress and inflammation in the nervous system, slowing the progression of the disease. Edaravone is administered intravenously and requires a medical prescription. Treatment with Edaravone involves cycles of daily infusions over a specified period. It is important to follow medical guidelines regarding the correct dosage, appropriate frequency of administration, and duration of treatment.

$325.00

Additional information

Active Ingredient

Edaravone

Indication

ALS – Amyotrophic Lateral Sclerosis (Esclerose Lateral Amiotrófica)

Origin

United States of America

Packaging

2 vials

Storage Temperature

Controlled room temperature

Strength

30 mg/100 ml